CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,604 enrolled
Drug / intervention
Reveal LINQdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02746471
NCT02746471N/ACompleted
CompareCT.gov

Medtronic Reveal LINQ Insertable Cardiac Monitor Registry

Medtronic Cardiac Rhythm and Heart Failure·observational·Posted Apr 21, 2016·Updated Jul 18, 2022

In Brief

An observational study evaluating Reveal LINQ for Arrhythmias, Cardiac. Completed, enrolled 1,604 participants across 48 sites in 9 countries.

Detailed Summary

The Reveal LINQ Registry will generate reliable long-term "real world" data of product performance, economic valuation, site-of-service procedural information.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsArrhythmias, Cardiac
CountriesBelgium, Greece, Israel, Italy, Japan, Netherlands, Portugal, Saudi Arabia, United States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 21, 2016
Enrollment StartApr 1, 2014
Primary CompletionJun 4, 2021
TodayJul 2, 2026
Enrollment to primary: 7.2 yearsPosted 10.2 years ago

Interventions

Reveal LINQdevice